Sep / 2025

OncoDaily IO OncoDaily GI Hemostasis Today

Insight

Oct 15, 2023 5:54 pm

Oct 15, 2023 4:12 pm

Oct 15, 2023 3:11 pm

Oct 15, 2023 1:12 pm

Oct 14, 2023 4:59 pm

Oct 14, 2023 4:42 pm

Oct 14, 2023 4:32 pm

Oct 13, 2023 5:38 pm

Oct 13, 2023 12:23 pm

Oct 12, 2023 8:57 pm

…

773

…

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

Insight

Balazs Halmos: 4.1% annual drop in lung cancer deaths! If we keep this pace (or speed up) – can u imagine what might happen?

Venky (Venkatraman Radhakrishnan): On multivariate analysis NCI high risk, MRD positive and CD 20 positive associated with inferior survival

Aruni Ghose: We did not identify diﬀerences in the management or short-term outcomes of patients with OPSCC treated at Barts Cancer Centre before and during the COVID-19 pandemic

Nalee Kim: We recently found out that selective high dose RT to primary breast tumor even in metastatic setting showed favorable LC outcomes.

A nice article about the potential impact of the SIO-ASCO guidelines on depression and anxiety on quality of cancer care. – Society for Integrative Oncology

Mathieu Sertorio: Collaborative study – Development of a Single-Neurosphere Culture to Assess Radiation Toxicity and Pre-Clinical Cancer Combination Therapy Safety

Daniel Chen: After a decade of immense progress for patients with cancer immunotherapy we are excited to publish a 10-year update, reflecting the complexity in the TME

Akshat Jain: “Mending The Pain” is a piece devoted to warriors fighting pain from disease

Leticia Nogueira: If you think the greatest impact of Climate Change on Cancer is through increased risk of melanoma, read this article

Erika Hamilton: Excited to see further updates from monarchE at ESMO23

Headlines

Insight

Balazs Halmos: 4.1% annual drop in lung cancer deaths! If we keep this pace (or speed up) – can u imagine what might happen?

Venky (Venkatraman Radhakrishnan): On multivariate analysis NCI high risk, MRD positive and CD 20 positive associated with inferior survival

Aruni Ghose: We did not identify diﬀerences in the management or short-term outcomes of patients with OPSCC treated at Barts Cancer Centre before and during the COVID-19 pandemic

Nalee Kim: We recently found out that selective high dose RT to primary breast tumor even in metastatic setting showed favorable LC outcomes.

A nice article about the potential impact of the SIO-ASCO guidelines on depression and anxiety on quality of cancer care. – Society for Integrative Oncology

Mathieu Sertorio: Collaborative study – Development of a Single-Neurosphere Culture to Assess Radiation Toxicity and Pre-Clinical Cancer Combination Therapy Safety

Daniel Chen: After a decade of immense progress for patients with cancer immunotherapy we are excited to publish a 10-year update, reflecting the complexity in the TME

Akshat Jain: “Mending The Pain” is a piece devoted to warriors fighting pain from disease

Leticia Nogueira: If you think the greatest impact of Climate Change on Cancer is through increased risk of melanoma, read this article

Erika Hamilton: Excited to see further updates from monarchE at ESMO23

Headlines

OncoDaily

Oncology

cancer

fight against cancer

Global fight against cancer

cancer care

Breast Cancer

ASCO

Lung cancer

Cancer research

MD Anderson Cancer Center

cancer awareness

NSCLC

ESMO

immunotherapy

cancer treatment

Research

ASCO24

Headlines

colorectal cancer

Childhood Cancer

prostate cancer

AACR

clinical trials

FDA

Dana-Farber Cancer Institute

UICC

American Cancer Society

European Cancer Organisation

NCI

National Cancer Institute

healthcare

SIOP

ASCO25

chemotherapy

Vivek Subbiah

AI

American Society of Clinical Oncology

Paolo Tarantino

IASLC

WHO

Robert Orlowski

multiple myeloma

Memorial Sloan Kettering Cancer Center

Zainab Shinkafi-Bagudu

radiation oncology

Myeloma Paper of the Day

cervical cancer

Myeloma

patient care

European School of Oncology

Sitemap